Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 4 boards, counting each seat separately. Longest: Cardio Diagnostics Holdings Inc., 3 years.
Cardio Diagnostics Holdings Inc.
Director
Nutex Health Inc.
Director · President
General Purpose Acquisition Corp.
Director
Veraxa Biotech AG
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cardio Diagnostics Holdings Inc. September 18, 202684.2%
-
Nutex Health Inc. April 23, 202695.1%
-
Cardio Diagnostics Holdings Inc. October 15, 202592.4%
-
Cardio Diagnostics Holdings Inc. November 15, 202476.7%
-
Nutex Health Inc. June 14, 202485.3%
-
Cardio Diagnostics Holdings Inc. December 18, 202393.9%
-
Nutex Health Inc. June 29, 202387.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2026 | Nutex Health Inc. | Open-market purchase | +252 | $94.07 | $23,706 |
| Mar 10, 2026 | Nutex Health Inc. | Option exercise | +6,293 | — | — |
| Mar 10, 2026 | Nutex Health Inc. | Shares withheld for tax | −3,274 | $86.22 | $282,284 |
| Apr 4, 2025 | Nutex Health Inc. | Shares withheld for tax | −1,072 | $72.10 | $77,291 |
| Mar 1, 2025 | Nutex Health Inc. | Option exercise | +3,776 | — | — |
| Sep 22, 2023 | Nutex Health Inc. | Gift | −141,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.